Piloting Single Session Consultation for Cancer (SSC-C) to Alleviate Distress Among Breast Cancer Patients

Status: Recruiting
Location: See all (7) locations...
Intervention Type: Behavioral, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to see if a Single Counseling Session for Cancer can help reduce psychosocial distress and improve quality of life in people with breast cancer who are waiting to receive ongoing counseling services (outpatient psychotherapy services). The Single Counseling Session for Cancer-which I will refer to as the study counseling during this call-is a one-session, 60-minute counseling program designed to reduce anxiety and depression symptoms in people with cancer who are waiting to receive outpatient psychotherapy services. The researchers will look at whether the study counseling is effective in participants and practical (feasible) for them to complete.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient must have pathologically confirmed breast cancer (per EMR).

• Patient with localized or advanced cancer (per EMR).

• Patient is on a waitlist of at least 2 weeks or more for MSK Counseling Center intake and will not complete a Counseling Center intake prior to intervention (these patients will be replaced) (per EMR, patient's care team, or self-report).

• Has no current active or passive suicidal ideation (per self-report of PHQ-9, Item 9: Thoughts that you would be better off dead, or of hurting yourself).

• Female (per EMR)

• Age ≥ 18 (per EMR)

• English fluency - Per self-report: How well do you speak English?

• Agrees to be audio-recorded (per self-report) NOTE: Participants who report Very well are considered fluent.

• Lives in New York, New Jersey, or Connecticut (per self-report).

• Has no significant psychiatric disturbance sufficient to preclude completion of the assessment measures, interview, or informed consent (i.e., acute psychiatric symptoms which require urgent or extended individual treatment) (per EMR, patient's care team, or study team).

• Has no presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per EMR, patient's care team, or per self-report of BOMC cognitive test).

• Has no current active or passive suicidal ideation (per item 9 of the PHQ-9 and the CSSRS).

Locations
United States
New Jersey
Memorial Sloan Kettering Basking Ridge (Consent Only)
RECRUITING
Basking Ridge
Memorial Sloan Kettering Monmouth (Consent Only)
RECRUITING
Middletown
Memorial Sloan Kettering Bergen (Consent Only)
RECRUITING
Montvale
New York
Memorial Sloan Kettering Suffolk- Commack (Consent Only)
RECRUITING
Commack
Memorial Sloan Kettering Westchester (Consent Only)
RECRUITING
Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITING
New York
Memorial Sloan Kettering Nassau (Consent Only)
RECRUITING
Uniondale
Contact Information
Primary
Devika Jutagir, PhD
jutagird@mskcc.org
646-888-8361
Backup
Francesca Gany, MD, MS
646-888-8054
Time Frame
Start Date: 2025-10-15
Estimated Completion Date: 2026-10
Participants
Target number of participants: 20
Treatments
Experimental: SSC-C - Single Session Consultation for Cancer
will receive the study counseling
Active_comparator: PPSB - Psychosocial Patient Support Booklet
will receive an American Cancer Society booklet for review (and no counseling)
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center
Collaborators: The City College of New York

This content was sourced from clinicaltrials.gov